Addiction Science & Clinical Practice

Papers
(The TQCC of Addiction Science & Clinical Practice is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Psychometric properties of the cannabis abuse screening test (CAST) in a sample of Moroccans with cannabis use74
Examining outcomes for service users accessing the Breaking Free Online computer-assisted therapy program for substance use disorders via a ‘telehealth’ approach: protocol for a two arm, parallel grou53
Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series47
Improving alcohol and substance use screening in school-age children: translation, adaptation and psychometric evaluation of the CRAFFT tool for Lumasaaba, Uganda36
Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals35
Reimagining brief interventions for alcohol: towards a paradigm fit for the twenty first century?33
Is it about substituting an addiction with another? development and initial psychometric properties of the first heated tobacco products addiction questionnaire (HeaTPAQ)30
Virtual reality cue exposure as an add-on to smoking cessation group therapy: a randomized controlled trial28
Problematic substance use among patients in a Swedish outpatient psychiatry setting: staff and manager perceptions of digital options for increased intervention access27
Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: findings from a NIDA clinical trials network site selection process27
Tobacco cessation among smokers under substance use treatment for alcohol and/or cannabis: study protocol and pilot study25
A Descriptive analysis of urine drug screen results in patients with opioid use disorder managed in a primary care setting23
Rationale and design of a randomized clinical trial of integrated eHealth for PrEP and medications for opioid use disorders for women in the criminal legal system. The Athena study22
“At least someone thinks I’m doing well”: a real-world evaluation of the quit-smoking app StopCoach for lower socio-economic status smokers21
Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial19
Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study19
Correction: Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population19
Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder18
Effectiveness of a culturally tailored HIV intervention in promoting PrEP among black women who use drugs in community supervision programs in New York City: a randomized clinical trial17
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use16
Physician blame and vulnerability: novel predictors of physician willingness to work with patients who misuse opioids16
Should screening for risk of gambling-related harm be undertaken in health, care and support settings? A systematic review of the international evidence15
Patient evaluation of a smartphone application for telehealth care of opioid use disorder15
Correction: Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis15
The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State15
What smartphone apps exist to support recovery from opioid use disorder? A content analysis of publicly available opioid-related smartphone apps14
Patient centered medication treatment for opioid use disorder in rural Vermont: a qualitative study14
Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation13
“There’s always somebody that you can identify with”: a qualitative study of patient perspectives on buprenorphine group medical visits13
Proceedings of the 18th Annual Conference of INEBRIA13
Facilitating rapid access to addiction treatment: a randomized controlled trial13
A systematic review of substance use screening in outpatient behavioral health settings13
“Take services to the people”: strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda13
mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with metham13
Pre-exposure prophylaxis (PrEP) among people who use drugs: a qualitative scoping review of implementation determinants and change methods13
Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder12
Preliminary feasibility of integrating tobacco treatment into SUD peer recovery coaching: a mixed-methods study of peer recovery coaches12
Integrating substance use peer support and screening brief intervention and referral to treatment services in the emergency department: a descriptive study of the ED leads program12
Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis11
Methadone clinic staff perceptions of trauma-informed and patient-centered care: the role of individual staff characteristics11
Smoking cessation using preference-based tools: a mixed method pilot study of a novel intervention among smokers with low socioeconomic position11
Healthcare staff’s perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study11
Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems10
Chronic unilateral groin pain in a young patient who injects drugs: a case report of needle fragment retentions10
A stakeholder-driven approach to designing a peer recovery coach role for implementation in community-oriented primary care teams in South Africa10
The development and initial validation of the Russian version of the BASIS-2410
Substance use disorder bridge clinics: models, evidence, and future directions10
Patient characteristics associated with their level of twelve-step attendance prior to entry into treatment for substance use disorders9
Developing practical strategies to reduce addiction-related stigma and discrimination in public addiction treatment centers: a mixed-methods study protocol9
Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants9
Patient experiences of buprenorphine dispensing from a mobile medical unit9
Automated Reinforcement Management System (ARMS): focused phase I provider feedback9
Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 20188
Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey8
The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic8
The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis8
Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods8
Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use d8
Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule8
Discharge locations after hospitalizations involving opioid use disorder among medicare beneficiaries8
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder8
Organizational perspectives on the impacts of scaling up overdose education and naloxone distribution in Kentucky7
Rethinking trazodone for insomnia in alcohol use disorder7
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 rec7
Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial7
Comparison of heroin and fentanyl use in US nationally representative surveys7
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versu6
CTN-0138: adaptation, implementation, and cluster randomized trial of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool—a protocol paper6
Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology6
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder6
The Spanish language version of the TAPS tool: protocol for a validation and implementation study in primary care6
The associations between public stigma and support for others’ help-seeking for alcohol use disorder: a cross sectional study in the general Danish population6
Training health professionals to reduce overreporting of birthing people who use drugs to child welfare6
The measurement-based care to opioid treatment programs project (MBC2OTP): a study protocol using rapid assessment procedure informed clinical ethnography6
Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative6
Using mixed methods to establish tobacco treatment acceptability from the perspective of clients and clinicians of antenatal substance use services6
Proceedings of the 17th Annual International INEBRIA Conference6
Coping motives mediate the relationship between PTSD and MDMA use in adolescents with substance use disorders6
Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates6
Attitudes and training related to substance use in pediatric emergency departments6
Effectiveness and feasibility of a motivational interviewing intake (MII) intervention for increasing client engagement in outpatient addiction treatment: an effectiveness-implementation hybrid design6
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: an updated systematic review6
Study design to evaluate a web-intervention to prevent alcohol and cannabis-impaired driving and use among adolescents in driver education5
Preliminary study of alcohol problem severity and response to brief intervention5
Housing, opportunities, motivation and engagement (HOME) for homeless youth at-risk for opioid use disorder: study protocol for a randomized controlled trial5
Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study5
Support after return to alcohol use: a mixed-methods study on how abstinence motivation and app use change after return to alcohol use in an app-based aftercare intervention for individuals with alcoh5
Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities5
Improving Treatment Together: a protocol for a multi-phase, community-based participatory, and co-design project to improve youth opioid treatment service experiences in British Columbia5
“It’s all about asking from those who have walked the path”: Patient and stakeholder perspectives on how peers may shift substance use stigma in HIV care in South Africa5
Hospital admissions among patients with Comorbid Substance Use disorders: a secondary analysis of predictors from the NavSTAR Trial5
Perspectives of healthcare workers on the integration of overdose detection technologies in acute care settings5
Improving alcohol health literacy and reducing alcohol consumption: recommendations for Germany5
Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services5
Ketamine-assisted buprenorphine initiation: a pilot case series5
Effects of service-wide support on regularity of alcohol screening of clients in Australian Aboriginal and Torres Strait Islander Community Controlled Health Services: a cluster randomised trial5
PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs5
The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review5
Prevalence and predictors of suicidality among adults initiating office-based buprenorphine5
“We need all hands on deck”: characterizing addiction medicine training in Canada—a mixed methods study of fellowship program directors5
Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway5
Grayken Lessons: a patient who developed opioid use disorder after traumatic brain injury5
Care-engaged individuals with polysubstance use in Northeastern US are undertreated for methamphetamine use disorder: a retrospective cohort study5
0.051687002182007